MII IG Medikation
2027.0.0-ballot - Germany

This page is part of the MII Implementation Guide MII IG Medikation (v2027.0.0-ballot: 2027 Ballot 2) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Beispiel Medication: mii-exa-medikation-medication-caelyx

German

code: Caelyx pegylated liposomal 2 mg/ml Konzentrat zur Herstellung einer Infusionslösung 1x25ml DSF N1

status: Active

form: Concentrate for solution for infusion

Ingredients

-Item[x]IsActiveStrength
*DOXORUBICIN HYDROCHLORIDEtrue50 mg (Details: UCUM codemg = 'mg')/25 ml (Details: UCUM codeml = 'ml')